170 related articles for article (PubMed ID: 17965539)
1. Effects of azimilide on the muscarinic acetylcholine receptor-operated K+ current and experimental atrial fibrillation in guinea-pig hearts.
Nishida A; Reien Y; Ogura T; Uemura H; Tamagawa M; Yabana H; Nakaya H
J Pharmacol Sci; 2007 Nov; 105(3):229-39. PubMed ID: 17965539
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts.
Nakaya H; Furusawa Y; Ogura T; Tamagawa M; Uemura H
Br J Pharmacol; 2000 Dec; 131(7):1363-72. PubMed ID: 11090108
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of aprindine on the delayed rectifier K+ current and the muscarinic acetylcholine receptor-operated K+ current in guinea-pig atrial cells.
Ohmoto-Sekine Y; Uemura H; Tamagawa M; Nakaya H
Br J Pharmacol; 1999 Feb; 126(3):751-61. PubMed ID: 10188988
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of amiodarone on the muscarinic acetylcholine receptor-operated potassium current in guinea pig atrial cells.
Watanabe Y; Hara Y; Tamagawa M; Nakaya H
J Pharmacol Exp Ther; 1996 Nov; 279(2):617-24. PubMed ID: 8930164
[TBL] [Abstract][Full Text] [Related]
5. SD-3212, a new class I and IV antiarrhythmic drug: a potent inhibitor of the muscarinic acetylcholine-receptor-operated potassium current in guinea-pig atrial cells.
Hara Y; Nakaya H
Br J Pharmacol; 1995 Nov; 116(6):2750-6. PubMed ID: 8591000
[TBL] [Abstract][Full Text] [Related]
6. Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells. Different molecular mechanisms.
Mori K; Hara Y; Saito T; Masuda Y; Nakaya H
Circulation; 1995 Jun; 91(11):2834-43. PubMed ID: 7758191
[TBL] [Abstract][Full Text] [Related]
7. Use-dependent effects of the class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: block of delayed rectifier potassium and L-type calcium currents.
Fermini B; Jurkiewicz NK; Jow B; Guinosso PJ; Baskin EP; Lynch JJ; Salata JJ
J Cardiovasc Pharmacol; 1995 Aug; 26(2):259-71. PubMed ID: 7475051
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the rate-dependent properties of the class III antiarrhythmic agents azimilide (NE-10064) and E-4031: considerations on the mechanism of reverse rate-dependent action potential prolongation.
Groh WJ; Gibson KJ; Maylie JG
J Cardiovasc Electrophysiol; 1997 May; 8(5):529-36. PubMed ID: 9160229
[TBL] [Abstract][Full Text] [Related]
9. Azimilide causes reverse rate-dependent block while reducing both components of delayed-rectifier current in canine ventricular myocytes.
Gintant GA
J Cardiovasc Pharmacol; 1998 Jun; 31(6):945-53. PubMed ID: 9641481
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of muscarinic potassium current by the class III antiarrhythmic drug RP58866 in guinea-pig atrial myocytes.
Brandts B; Van Bracht M; Tüttelmann F; Allessie MA; Trappe HJ
Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1812-5. PubMed ID: 11139931
[TBL] [Abstract][Full Text] [Related]
11. Effects of mitoxantrone on action potential and membrane currents in isolated cardiac myocytes.
Wang GX; Zhou XB; Eschenhagen T; Korth M
Br J Pharmacol; 1999 May; 127(2):321-30. PubMed ID: 10385229
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of dronedarone on muscarinic K+ current in guinea pig atrial cells.
Guillemare E; Marion A; Nisato D; Gautier P
J Cardiovasc Pharmacol; 2000 Dec; 36(6):802-5. PubMed ID: 11117382
[TBL] [Abstract][Full Text] [Related]
13. Azimilide (NE-10064) can prolong or shorten the action potential duration in canine ventricular myocytes: dependence on blockade of K, Ca, and Na channels.
Yao JA; Tseng GN
J Cardiovasc Electrophysiol; 1997 Feb; 8(2):184-98. PubMed ID: 9048249
[TBL] [Abstract][Full Text] [Related]
14. Effects of the novel antiarrhythmic agent azimilide on experimental atrial fibrillation and atrial electrophysiologic properties.
Nattel S; Liu L; St-Georges D
Cardiovasc Res; 1998 Mar; 37(3):627-35. PubMed ID: 9659446
[TBL] [Abstract][Full Text] [Related]
15. Effects on atrial repolarization of the interaction between K+ channel blockers and muscarinic receptor stimulation.
Zaza A; Malfatto G; Schwartz PJ
J Pharmacol Exp Ther; 1995 Jun; 273(3):1095-104. PubMed ID: 7791080
[TBL] [Abstract][Full Text] [Related]
16. Azimilide inhibits multiple cardiac potassium currents in human atrial myocytes.
Chen F; Esmailian F; Sun W; Wetzel GT; Sarma JS; Singh BN; Klitzner TS
J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):255-64. PubMed ID: 12490972
[TBL] [Abstract][Full Text] [Related]
17. Impaired Na⁺-dependent regulation of acetylcholine-activated inward-rectifier K⁺ current modulates action potential rate dependence in patients with chronic atrial fibrillation.
Voigt N; Heijman J; Trausch A; Mintert-Jancke E; Pott L; Ravens U; Dobrev D
J Mol Cell Cardiol; 2013 Aug; 61():142-52. PubMed ID: 23531443
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of G protein-coupled and ATP-sensitive potassium currents by 2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015), an amiodarone derivative.
Brandts B; Borchard R; Macianskiene R; Gendviliene V; Dirkmann D; Van Bracht M; Prull M; Meine M; Wickenbrock I; Mubagwa K; Trappe HJ
J Pharmacol Exp Ther; 2004 Jan; 308(1):134-42. PubMed ID: 14569071
[TBL] [Abstract][Full Text] [Related]
19. Pirmenol inhibits muscarinic acetylcholine receptor-operated K+ current in the guinea pig heart.
Watanabe Y; Hara Y; Tamagawa M; Nakaya H
Eur J Pharmacol; 1997 Oct; 338(1):71-4. PubMed ID: 9408005
[TBL] [Abstract][Full Text] [Related]
20. Interaction of azimilide with neurohumoral and channel receptors.
Brooks RR; Pong SF; Izzo NJ; Moorehead TJ; Gopalakrishnan M; Triggle DJ
Biochem Pharmacol; 2001 Oct; 62(7):883-92. PubMed ID: 11543723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
